GLP-1 Users Face Digestive and Vision Injury Claims
Adults using these weight-loss drugs in Phoenix are seeing reported side effects that researchers are still working to understand.
Updated on Nov. 4, 2026 in Health

Live Poll
Would you take a GLP-1 medication despite its possible side effects?
Phillips Law Group, which has an Uptown Phoenix location, represents about 20 clients with claims tied to GLP-1 medication injuries, including digestive problems and vision-related complications. The firm has two litigations, one covering gastrointestinal issues and one covering non-arteritic anterior ischemic optic neuropathy (NAION).
Why it matters
GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Zepbound and Rybelsus are widely used for weight loss and blood sugar control, so the reported injury claims bear on how Phoenix-area patients weigh benefits against side effects. Lawyers argue manufacturers may not have adequately warned patients about the risk of severe digestive complications.
The figures come from a single law firm's caseload rather than a controlled study, so they describe claims filed, not confirmed causation. Separate published research has reported a possible association between semaglutides and NAION, but the data are not yet sufficient to conclude that patients should stop taking their medications.
The players
Phillips Law Group
A law firm with an Uptown Phoenix location that represents about 20 clients with GLP-1 medication injury claims.
American Academy of Ophthalmology
A professional medical association whose journal published studies examining a possible link between semaglutides and NAION.
The details
GLP-1 medications act on the gut-brain connection that regulates hunger and fullness, which is why gastrointestinal effects are the most common side effects reported. Symptoms, including acid reflux, are often most noticeable during the first 24 to 48 hours after an injection. Many GI effects can be managed through hydration, fiber intake of 20 to 30 grams daily, minimally processed foods, and limiting greasy or high-fat meals. The 7.2 milligram dose of Wegovy can cause a sunburn-like sensation, and semaglutides can increase the risk of pancreatitis in patients previously diagnosed with it.
Timeline
March: The American Academy of Ophthalmology Journal published NAION studies on semaglutides.
Since FDA approval: Semaglutides have helped patients lower BMI and A1C.
Health Landscape
Semaglutides have become central to obesity and diabetes treatment since their FDA approval, with patients reporting lower BMI and A1C. The rise in injury claims reflects growing attention to side effects as these drugs move from specialty use into broad everyday use.
If you take a GLP-1 medication and notice persistent digestive symptoms or any sudden vision changes, it is worth raising them with your doctor promptly. Keeping meals smaller and more frequent, and tracking fiber and hydration, may help manage common GI effects, but any change to your treatment should be discussed with your physician first.
The takeaway
Persistent GI symptoms and any sudden vision changes on a GLP-1 medication are worth reporting to your doctor. Eating small, frequent meals every three to four hours and staying hydrated are commonly suggested habits to discuss with your care team.
Further reading
For more on the treatments at the center of these claims, see our Weight Loss coverage.
Source note: This article includes information reported by AZ Big Media.
Live Poll
Would you take a GLP-1 medication despite its possible side effects?




